In an 86-year-old woman presenting with hourly daytime urinary frequency, nocturia, suprapubic pain radiating to the right iliac fossa, sterile urine culture, and a poorly distended bladder on ultrasound, what are the most likely differential diagnoses, the recommended investigations (including post‑void residual measurement, urodynamic studies, and cystoscopy), and a stepwise management plan (non‑pharmacologic measures, first‑line pharmacologic options, escalation criteria, and red‑flag signs)?

Diagnostic Assessment: Interstitial Cystitis/Bladder Pain Syndrome Most Likely

This 86-year-old woman's presentation—hourly urinary frequency, nocturia, suprapubic pain radiating to the right iliac fossa, sterile urine culture, and poorly distended bladder—is most consistent with interstitial cystitis/bladder pain syndrome (IC/BPS), though overactive bladder (OAB) remains in the differential. The key distinguishing feature is the pain component, which is central to IC/BPS but not to OAB 1.

Most Likely Differential Diagnoses

Primary Considerations:

1. Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) - Most likely

   • Bladder/pelvic pain with pressure/discomfort
   • Urinary frequency (10-15 times/day is severe)
   • Nocturia (4 times/night)
   • Sterile urine culture
   • Symptoms present >6 weeks required for diagnosis 1
   • Pain location (suprapubic extending to RIF) fits the pelvic pain pattern

2. Overactive Bladder (OAB) - Second consideration

   • Severe frequency and nocturia present
   • However, OAB typically lacks the pain component that dominates this presentation 2
   • The poorly distended bladder suggests reduced functional capacity, seen in both conditions

3. Underactive Bladder/Detrusor Underactivity - Must exclude

   • Can present with frequency, urgency, weak stream 3
   • The poorly distended bladder on ultrasound raises this concern
   • Critical to measure post-void residual (PVR) to exclude retention

Less Likely but Consider:

• Right-sided pathology (appendicitis, ovarian pathology, diverticulitis): The sterile urine, absence of fever, and normal imaging make intra-abdominal pathology unlikely, but the RIF pain warrants consideration if symptoms worsen
• Neurogenic bladder: No neurological history mentioned; brief neuro exam needed 1

Key Differentiating Features: IC/BPS vs OAB

IC/BPS Characteristics (Present in This Case):

• Pain, pressure, or discomfort in bladder/pelvic region (suprapubic to RIF) 1
• Pain often worsens with bladder filling
• Reduced bladder capacity (poorly distended bladder on ultrasound)
• Symptoms chronic (>6 weeks) 1

OAB Characteristics (Partially Present):

• Urgency with or without urgency incontinence
• Frequency and nocturia
• Absence of pain is the hallmark difference 2

The presence of pain makes IC/BPS the leading diagnosis 1.

Recommended Investigations

Essential Initial Workup:

1. Post-Void Residual (PVR) Measurement - MANDATORY FIRST STEP

   • Must exclude urinary retention/underactive bladder 3
   • Elevated PVR (>100-150 mL) would completely change management
   • Can be done via bladder ultrasound or catheterization
   • This is critical in an 86-year-old with "poorly distended bladder" 2, 1

2. Bladder Diary (Frequency-Volume Chart) - ESSENTIAL

   • Minimum 1-day diary, ideally 3-day 1
   • Documents voiding frequency, voided volumes, fluid intake
   • Helps identify nocturnal polyuria (75% prevalence in women with nocturia) 4
   • Calculates functional bladder capacity
   • Establishes baseline for treatment response 1

3. Validated Symptom Questionnaires

   • Patient Perception of Bladder Condition (PPBC)
   • Bladder Pain/Interstitial Cystitis Symptom Score (BPIC-SS)
   • Patient Global Impression of Severity (PGI-S) 5
   • These establish baseline severity and quality of life impact 1

Cystoscopy Indications:

Cystoscopy should be performed if Hunner lesions are suspected 1. Indications include:

• Patients with severe pain and reduced bladder capacity
• Those who fail initial behavioral/medical therapy
• To rule out bladder cancer (especially with tobacco exposure or hematuria) 1
• Hunner lesions are the only consistent cystoscopic finding diagnostic for IC/BPS and respond well to treatment 1
• Can be done as office flexible cystoscopy or under anesthesia based on patient tolerance 1

Urodynamic Studies:

Generally NOT recommended for routine IC/BPS diagnosis 1. Consider only if:

• Suspicion of outlet obstruction
• Concern for poor detrusor contractility (given the poorly distended bladder)
• Patient refractory to multiple therapies
• Need to exclude other conditions explaining treatment failure 1

Additional Considerations:

• Brief neurological examination to exclude occult neurologic problems 1
• Pelvic examination to assess for pelvic organ prolapse, pelvic floor tenderness, myofascial pain 1, 5
• Review medications (diuretics, timing) 6
• Assess for comorbidities: constipation, diabetes, obesity 2

Stepwise Management Plan for 86-Year-Old Patient

The 2022 IC/BPS guideline no longer uses tiered treatment; instead, treatment should be individualized using concurrent, multi-modal therapies based on patient characteristics 1. However, for practical geriatric management:

Phase 1: Behavioral/Non-Pharmacologic Therapies (Start Immediately)

These are foundational and should be initiated for all patients 2, 1:

1. Fluid Management

   • Avoid excessive fluid intake, especially before bedtime
   • Limit fluids 2-3 hours before sleep to reduce nocturia 6
   • Maintain adequate hydration during daytime

2. Bladder Irritant Avoidance

   • Eliminate caffeine and alcohol 2
   • Avoid acidic foods, artificial sweeteners, spicy foods

3. Timed Voiding

   • Scheduled voiding every 2-3 hours while awake
   • Prevents urgency episodes 2

4. Urgency Suppression Techniques

   • Teach pelvic floor contraction to suppress urgency
   • Distraction techniques 2

5. Pelvic Floor Physical Therapy

   • If myofascial pelvic pain present (28.4% of IC/BPS patients) 5
   • Biofeedback may help 2

6. Optimize Comorbidities

   • Manage constipation aggressively 2
   • Review and adjust timing of diuretics if present 6
   • Control diabetes, hypertension 2
   • Address genitourinary syndrome of menopause 2

Phase 2: Pharmacologic Therapy (Consider Early, Especially for Pain)

For IC/BPS with pain, oral medications are appropriate first-line therapy alongside behavioral measures 1:

First-Line Oral Options:

1. Amitriptyline (tricyclic antidepressant)

   • Start 10-25 mg at bedtime
   • Caution in elderly: anticholinergic effects (confusion, falls, urinary retention)
   • Monitor closely; may help with pain and sleep
   • Titrate slowly in geriatric patients

2. Pentosan Polysulfate (Elmiron)

   • Important 2022 update: Associated with pigmentary maculopathy and vision changes 1
   • Requires ophthalmologic screening before and during treatment
   • Use with extreme caution in 86-year-old; shared decision-making essential 1

3. Hydroxyzine (antihistamine)

   • May help with pain and sleep
   • Caution: sedation and anticholinergic effects in elderly

If OAB Component Predominates:

1. Beta-3 Agonist (Mirabegron) - PREFERRED in elderly

   • Fewer anticholinergic side effects than antimuscarinics 2
   • Start 25 mg daily, can increase to 50 mg
   • Monitor blood pressure (can increase BP slightly)

2. Antimuscarinics - USE WITH EXTREME CAUTION in 86-year-old

   • High risk of cognitive impairment, falls, constipation, urinary retention 2
   • If used, prefer newer agents with less CNS penetration (darifenacin, solifenacin)
   • Avoid in patients with cognitive impairment

Phase 3: Minimally Invasive Therapies (If Inadequate Response at 6-12 Weeks)

1. Bladder Instillations

   • DMSO (dimethyl sulfoxide) instillations
   • Lidocaine/heparin cocktails
   • Requires office visits; may be challenging for 86-year-old

2. Onabotulinum Toxin A (Botox) Injection

   • 100 units intravesical injection 2
   • Risk: urinary retention requiring intermittent catheterization
   • In 86-year-old, assess ability to perform self-catheterization if needed

3. Sacral Neuromodulation

   • Percutaneous tibial nerve stimulation (PTNS) 2
   • Less invasive option
   • Requires weekly office visits initially

4. Cystoscopy with Fulguration/Resection of Hunner Lesions

   • If Hunner lesions identified, this is highly effective 1
   • Should be done early if lesions present 1

Phase 4: Major Surgery (Last Resort Only)

• Urinary diversion, bladder augmentation 2, 1
• Rarely appropriate in 86-year-old
• Only for refractory, debilitating cases

Red Flag Signs Requiring Urgent Evaluation

Immediate evaluation needed if:

1. Fever with flank pain - Suggests pyelonephritis despite sterile culture
2. Gross hematuria - Requires hematuria workup, cystoscopy to exclude malignancy 1
3. Acute urinary retention - Check PVR immediately
4. Severe, worsening RIF pain with peritoneal signs - Surgical abdomen (appendicitis, diverticulitis, ovarian torsion)
5. New neurological symptoms - Cauda equina syndrome, spinal cord compression
6. Acute kidney injury - Check renal function if oliguria develops
7. Sepsis signs - Despite sterile culture, consider atypical organisms

Practical Algorithm for This Patient

Step 1: Immediate Actions (Today)

• Measure post-void residual (bladder scan or catheterization)
• Start 3-day bladder diary
• Initiate behavioral therapies (fluid management, caffeine elimination, timed voiding)
• Administer symptom questionnaires (PPBC, BPIC-SS)
• Brief neurological exam and pelvic exam

Step 2: Based on PVR Results

If PVR >150 mL:

• Diagnosis is underactive bladder/retention
• Consider urodynamics
• Teach intermittent self-catheterization (if feasible at age 86)
• Avoid antimuscarinics

If PVR <100 mL:

• Proceed with IC/BPS vs OAB management
• Pain predominance → IC/BPS pathway
• Urgency/frequency without pain → OAB pathway

Step 3: Week 2-4

• Review bladder diary results
• If nocturnal polyuria identified (>33% of 24-hour urine output at night), address fluid timing and consider desmopressin (with caution for hyponatremia in elderly)
• Start oral medication based on predominant symptoms:
  • Pain dominant → Amitriptyline 10 mg qhs (monitor closely)
  • Frequency/urgency dominant → Mirabegron 25 mg daily
• Continue behavioral therapies

Step 4: Week 6-12

• Reassess symptoms with questionnaires
• If <50% improvement, consider:
  • Cystoscopy to evaluate for Hunner lesions 1
  • Add second medication or bladder instillations
  • Refer to pelvic floor physical therapy

Step 5: Beyond 12 Weeks

• If Hunner lesions found → Fulguration/resection
• If refractory → Consider Botox, neuromodulation
• Shared decision-making about risks/benefits in geriatric patient 1

Critical Pitfalls to Avoid

1. Failing to measure PVR - May miss urinary retention, leading to inappropriate antimuscarinic use
2. Assuming UTI without culture - Sterile pyuria common in IC/BPS; avoid unnecessary antibiotics
3. Using antimuscarinics in elderly without considering cognitive risks - High risk of delirium, falls 2
4. Dismissing pain as "just OAB" - Pain indicates IC/BPS, requires different approach 1
5. Delaying cystoscopy in suspected Hunner lesions - Early treatment highly effective 1
6. Ignoring nocturnal polyuria - Requires different management than bladder-centric causes 6, 4
7. Overlooking medication review - Diuretics, timing of administration affect nocturia 6
8. Not establishing baseline with bladder diary - Cannot assess treatment response without baseline 1